Latest News about Phase 1 Trial
Recent news which mentions Phase 1 Trial
Breaking Down Molly: Swiss University Studies How MDMA's Components Might Affect Humans
October 04, 2022
From Benzinga
From Benzinga
Sanofi's Rilzabrutinib Data In Autoimmune Blood Disorder Published In New England Journal of Medicine
April 14, 2022
Tickers
SNY
From Benzinga
From Benzinga
Cocrystal Pharma Posts Favorable Preliminary Data From Influenza A Antiviral Candidate Trial
April 12, 2022
Tickers
COCP
From Benzinga
From Benzinga
AIM ImmunoTech Shares Jump On Positive Data From Ampligen Study In Breast Cancer Setting
April 11, 2022
Tickers
AIM
From Benzinga
Portage Biotech Shares Encouraging Preliminary Safety Data From Lead iNKT Agonists Program In Cancer Patients
March 31, 2022
From Benzinga
EXCLUSIVE: Longeveron's Lomecel-B Data In Alzheimer's Disease Published In Medical Journal
March 31, 2022
Tickers
LGVN
From Benzinga
From Benzinga
Synthetic Biologics' VCN-01 Shows Favorable Safety Profile, Clinical Activity In Early-Stage Cancer Study
March 29, 2022
Tickers
SYN
From Benzinga
From Benzinga
Pluristem's PLX-R18 Shows Meaningful Advantage Over Other Treatments In Transplant Patients
March 23, 2022
Tickers
PSTI
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free
Information
Copyright 2024. BUSINESS INSURANCE HOLDINGS
